A Phase 1b Study of Telisotuzumab Vedotin in Combination With Nivolumab in Patients With NSCLC by Camidge, D. Ross, MD, PhD, Barlesi, Fabrice, MD, PhD, Goldman, Jonathan W., MD, Morgensztern, Daniel, MD, Heist, Rebecca, MD, MPH, Vokes, Everett, MD, Angevin, Eric, MD, PhD, Hong, David S., MD, Rybkin, Igor I., MD, Barve, Minal, MD, Bauer, Todd M., MD, Delmonte, Angelo, MD, Dunbar, Martin, DrPH, Motwani, Monica, PhD, Parikh, Apurvasena, PhD, Noon, Elysa, PhD, Wu, Jun, MD, Blot, Vincent, PhD, Kelly, Karen, MD

Get full text

Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastati... by Hensing, Thomas A., MD, Wang, Xiaofei, PhD, Stinchcombe, Thomas E., MD, Gao, Junheng, MS, Knopp, Michael V., MD, PhD, Watson, Mark, MD, PhD, Dudek, Arkadiusz Z., MD, PhD, Graziano, Stephen L., MD, Patel, Jyoti D., MD, Faller, Bryan A., MD, Dragnev, Konstantin H., MD, Kozono, David, MD, PhD, Vokes, Everett E., MD

Get full text

Induction Chemotherapy: To Use or Not to Use? That Is the Question by Brizel, David M., MD, Vokes, Everett E., MD

Get full text

Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study by Cohen, Ezra EW, Dr, Davis, Darren W, PhD, Karrison, Theodore G, PhD, Seiwert, Tanguy Y, MD, Wong, Stuart J, MD, Nattam, Sreenivasa, MD, Kozloff, Mark F, MD, Clark, Joseph I, MD, Yan, Duen-Hwa, PhD, Liu, Wen, MD, Pierce, Carolyn, BA, Dancey, Janet E, MD, Stenson, Kerstin, MD, Blair, Elizabeth, MD, Dekker, Allison, BSN, Vokes, Everett E, Prof

Get full text

Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol by Redman, Mary W, Prof, Papadimitrakopoulou, Vassiliki A, Prof, Minichiello, Katherine, MS, Hirsch, Fred R, Prof, Mack, Philip C, PhD, Schwartz, Lawrence H, Prof, Vokes, Everett, Prof, Ramalingam, Suresh, Prof, Leighl, Natasha, MD, Bradley, Jeff, Prof, Miao, Jieling, MS, Moon, James, MS, Highleyman, Louise, BS, Miwa, Crystal, BS, LeBlanc, Michael L, Prof, Malik, Shakun, MD, Miller, Vincent A, MD, Sigal, Ellen V, PhD, Adam, Stacey, PhD, Wholley, David, MS, Sigman, Caroline, PhD, Smolich, Beverly, PhD, Blanke, Charles D, Prof, Kelly, Karen, Prof, Gandara, David R, Prof, Herbst, Roy S, Prof

Get full text

Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis by Petit, Claire, MD, Lacas, Benjamin, PhD, Pignon, Jean-Pierre, MD, Le, Quynh Thu, MD, Grégoire, Vincent, Prof, Grau, Cai, Prof, Hackshaw, Allan, Prof, Zackrisson, Björn, MD, Parmar, Mahesh K B, Prof, Lee, Ju-Whei, PhD, Ghi, Maria Grazia, MD, Sanguineti, Giuseppe, MD, Temam, Stéphane, MD, Cheugoua-Zanetsie, Maurice, MSc, O'Sullivan, Brian, Prof, Posner, Marshall R, MD, Vokes, Everett E, MD, Cruz Hernandez, Juan J, MD, Szutkowski, Zbigniew, MD, Lartigau, Eric, MD, Budach, Volker, Prof, Suwiński, Rafal, Prof, Poulsen, Michael, Prof, Kumar, Shaleen, MD, Ghosh Laskar, Sarbani, Prof, Mazeron, Jean-Jacques, Prof, Jeremic, Branislav, Prof, Simes, John, Prof, Zhong, Lai-Ping, Prof, Overgaard, Jens, Prof, Fortpied, Catherine, MSc, Torres-Saavedra, Pedro, PhD, Bourhis, Jean, Prof, Aupérin, Anne, MD, Blanchard, Pierre, MD

Get full text

A phase I study of oral uracil/ftorafur (UFT) plus leucovorin and bis-acetato-ammine-dichloro-cyclohexylamine-platinum IV (JM-216) each given over 14 days every 28 days by DEMARIO, M. D, RATAIN, M. J, VOGELZANG, N. J, MANI, S, VOKES, E. E, FLEMING, G. F, MELTON, K, JOHNSON, S, BENNER, S, LEBWOHL, D

Get full text